[Serum levels of GPI, AAT and CEA in primary lung neoplasms and chronic bronchopneumopathies].
The Authors have tested serum levels of alpha-1-antitrypsin (A1AT), phosphohexose-isomerase (GPI) and carcinoembryonic antigen (CEA) in 133 patients affected with primary lung cancer, not treated with any drug, and in 183 patients affected with not neoplastic lung diseases or healthy, to control the utility of these markers in the early diagnosis of lung cancer. In many patients all the tests have been made at the same time. The three tumoral markers have been also examined in connection with the histological kinds of lung cancer. Results show that is suitable to test GIP and A1AT at the same time because they are percentually more pathological; serum levels of CEA, that are not very elevated in the pathological cases, seem in correlation with the histological kind of cancer.
D001982:Bronchial Diseases / Q000175:diagnosis; D002272:Carcinoembryonic Antigen; D002908:Chronic Disease; D005956:Glucose-6-Phosphate Isomerase / Q000097:blood*; D006801:Humans; D008171:Lung Diseases / Q000175:diagnosis; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000473:pathology; D000515:alpha 1-Antitrypsin / Q000378:metabolism*
D002272:Carcinoembryonic Antigen; D000515:alpha 1-Antitrypsin; D005956:Glucose-6-Phosphate Isomerase
I livelli sierici di GPI, A1AT e CEA nelle neoplasie polmonari primitive e nelle broncopneumopatie croniche.